RenovoRx

RenovoRx is a clinical-stage biopharmaceutical company dedicated to developing innovative targeted combination therapies for difficult-to-access cancers. They focus on improving treatment outcomes for cancer patients by developing transformative therapies that extend life and improve quality of life. Their proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform is designed to deliver therapies directly to the tumor while potentially minimizing toxicities. Their lead product candidate, RenovoGem, utilizes TAMP to deliver the FDA-approved chemotherapy gemcitabine to treat locally advanced pancreatic cancer (LAPC).

RenovoRx is committed to expanding their pipeline to treat additional cancers and exploring new commercial and clinical business development opportunities with their TAMP technology. RenovoGem has received FDA Orphan Drug Designation for pancreatic and bile duct cancer, providing them with market exclusivity for seven years upon NDA approval. They are currently conducting a Phase III clinical trial for LAPC and are preparing to launch a second Phase III trial for bile duct cancer. They are also exploring the application of RenovoGem for other solid tumors.

RenovoRx's job postings do not mention any specific details regarding job flexibility or remote work options.

RenovoRx offers a competitive compensation and benefits package that includes an annual bonus opportunity, stock options, medical/dental/vision insurance, a 401(k) with a match program, and paid holidays, vacation, and sick time.

RenovoRx is a clinical-stage biopharmaceutical company dedicated to improving outcomes for cancer patients by developing innovative, targeted combination therapies for high unmet medical needs. They focus on precision medicine solutions, particularly their proprietary Trans-Arterial Micro-Perfusion (TAMP) therapy platform, designed to deliver therapies directly to the tumor while minimizing systemic toxicity. Their aim is to provide safer, more tolerable, and effective treatments for cancer patients, ultimately improving quality of life and extending lifespans.

RenovoRx promotes a culture of impact, collaboration, growth, and ownership. They emphasize the opportunity for employees to make a meaningful contribution to the fight against cancer while working alongside a talented team. RenovoRx fosters a supportive environment where employees are encouraged to grow professionally and are recognized for their hard work and dedication.

RenovoRx is an Equal Opportunity Employer and values diversity. They provide equal employment opportunities to all employees and applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, age, disability, genetic characteristics, or any other category protected by applicable laws, regulations, and ordinances.